Results: 10
BCPT perspectives on studies involving natural products, traditional Chinese medicine and systems pharmacology.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 782, doi. 10.1111/bcpt.14109
- By:
- Publication type:
- Article
The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 705, doi. 10.1111/bcpt.14096
- By:
- Publication type:
- Article
Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 755, doi. 10.1111/bcpt.14095
- By:
- Publication type:
- Article
Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 743, doi. 10.1111/bcpt.14094
- By:
- Publication type:
- Article
Efficacy of weekly versus daily cholecalciferol for repleting serum vitamin D (25(OH)D) deficiency: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 685, doi. 10.1111/bcpt.14092
- By:
- Publication type:
- Article
Cytotoxicity, genotoxicity and mutagenicity of mixed ternary mononuclear Mg complex based on valproic acid with 1,10‐phenanthroline in Saccharomyces cerevisiae and V79 cells.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 767, doi. 10.1111/bcpt.14091
- By:
- Publication type:
- Article
An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 720, doi. 10.1111/bcpt.14090
- By:
- Publication type:
- Article
An overview of major depression disorder: The endocannabinoid system as a potential target for therapy.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 669, doi. 10.1111/bcpt.14089
- By:
- Publication type:
- Article
IL‐4 promotes chondrogenesis of bone marrow mesenchymal stem cells and blockade of IL‐4Rα retards the endochondral ossification during rat embryonic bone development.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 693, doi. 10.1111/bcpt.14088
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 667, doi. 10.1111/bcpt.13898
- Publication type:
- Article